Clinical Trial Update: Diazepam Trial in GAD65 Associated Epilepsy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating diazepam for GAD65 antibody-associated epilepsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gad65 Antibody-associated Epilepsy

Drugs mentioned

• Diazepam (Diazepam)

Snippet

Sponsor: Mayo Clinic | Conditions: GAD 65 Antibody-associated Epilepsy | Phase 1, Phase 2 | Status: WITHDRAWN